Novel Desmin Phosphorylation Sites Useful in Diagnosis and Intervention of Cardiac Disease

This invention relates to novel phosphorylation sites in the desmin protein that are associated with the onset of heart failure. The phosphorylation sites, i.e., Ser-27 and Ser-31, can be used as biomarkers for (i) identifying subjects at risk for the development of heart failure, (ii) treating subjects having a higher than normal level of the biomarker, and (iii) monitoring therapy of a subject at risk for the development of heart failure. Also described are antibodies, reagents, and kits for carrying out a method of the present invention.

Attached files:


Patents:
WO 2,010,138,610

Inventor(s): AGNETTI GIULIO [US]; VAN EYK JENNIFER [US]

Type of Offer: Licensing



« More Diagnostic Patents

---